Cetylated Fatty Acid for Reducing Pain After TKA

Last updated: March 1, 2024
Sponsor: Thammasat University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Acute Pain

Pain

Inflammation

Treatment

cetylated fatty acid

Placebo

Clinical Study ID

NCT06300008
OrthoTU13
  • Ages 50-80
  • All Genders

Study Summary

To compare efficacy of cetylated fatty acid with placebo for reducing postoperative pain after unilateral TKA. The hypothesis is topical cetylated fatty acid can mitigate postoperative pain after TKA.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 50-80 years
  • Osteoarthritic knee patients underwent unilateral primary TKA
  • Participants understand and consent to the protocol of the trial

Exclusion

Exclusion Criteria:

  • Inflammatory knee arthritis
  • Previous knee surgery or trauma
  • Previous knee infection
  • Skin problem around the knee such as eczema, psoriasis, wound infection
  • Allergy to studied drug

Study Design

Total Participants: 80
Treatment Group(s): 2
Primary Treatment: cetylated fatty acid
Phase:
Study Start date:
February 12, 2024
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • department of orthopaedic surgery, Faculty of medicine, Thammasat university

    Khlong Luang, Pathumthani 066
    Thailand

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.